Worland Stephen T
- SEC CIK
- 0001283307
No open-market purchases or sales filed in the past year.
Current role at each company
- EFTR eFFECTOR Therapeutics, Inc.Chief Executive Officeras of May 17, 2024
- TCON Tracon Pharmaceuticals, Inc.Directoras of Apr 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Worland Stephen T as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
EFTR eFFECTOR Therapeutics, Inc.
Chief Executive Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 9, 2022 (view filing) | Jun 7 | 2 days | Worland Stephen TPresident and Chief Executive | PPurchase | +20.0K | $1.37 | +$27.4K | +10.3%215.0K after |